BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 24362719)

  • 1. Reirradiation using high-dose-rate interstitial brachytherapy for locally recurrent cervical cancer: a single institutional experience.
    Mabuchi S; Takahashi R; Isohashi F; Yokoi T; Okazawa M; Sasano T; Maruoka S; Anzai M; Yoshioka Y; Ogawa K; Kimura T
    Int J Gynecol Cancer; 2014 Jan; 24(1):141-8. PubMed ID: 24362719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Image-guided interstitial high-dose-rate brachytherapy for locally recurrent uterine cervical cancer: A single-institution study.
    Umezawa R; Murakami N; Nakamura S; Wakita A; Okamoto H; Tsuchida K; Kashihara T; Kobayashi K; Harada K; Takahashi K; Inaba K; Ito Y; Igaki H; Masui K; Yoshida K; Jingu K; Tselis N; Itami J
    Brachytherapy; 2018; 17(2):368-376. PubMed ID: 29275869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Template-based high-dose-rate interstitial brachytherapy in gynecologic cancers: a single institutional experience.
    Mahantshetty U; Shrivastava S; Kalyani N; Banerjee S; Engineer R; Chopra S
    Brachytherapy; 2014; 13(4):337-42. PubMed ID: 24176863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcome of high-dose-rate interstitial brachytherapy in vulvar cancer: A single institutional experience.
    Mahantshetty U; Naga P; Engineer R; Sastri S; Ghadi Y; Upreti U; Somesan V; Kadam S; Kohle S; Deshpande D; Shrivastava SK
    Brachytherapy; 2017; 16(1):153-160. PubMed ID: 27876410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of progression-free survival and response to paclitaxel plus carboplatin in patients with recurrent or advanced cervical cancer.
    Hisamatsu T; Mabuchi S; Yoshino K; Fujita M; Enomoto T; Hamasaki T; Kimura T
    Int J Gynecol Cancer; 2012 May; 22(4):623-9. PubMed ID: 22343974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reirradiation with high-dose-rate remote afterloading brachytherapy implant in patients with locally recurrent or residual cervical carcinoma.
    Badakh DK; Grover AH
    J Cancer Res Ther; 2009; 5(1):24-30. PubMed ID: 19293485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of low and high dose rate brachytherapy in the treatment of uterine cervix cancer. Retrospective analysis of two sequential series.
    Ferrigno R; Nishimoto IN; Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Salvajoli JV
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1108-16. PubMed ID: 15990016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MR- versus CT-based high-dose-rate interstitial brachytherapy for vaginal recurrence of endometrial cancer.
    Kamran SC; Manuel MM; Catalano P; Cho L; Damato AL; Lee LJ; Schmidt EJ; Viswanathan AN
    Brachytherapy; 2017; 16(6):1159-1168. PubMed ID: 28823395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inverse Planned High-Dose-Rate Brachytherapy for Locoregionally Advanced Cervical Cancer: 4-Year Outcomes.
    Tinkle CL; Weinberg V; Chen LM; Littell R; Cunha JAM; Sethi RA; Chan JK; Hsu IC
    Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1093-1100. PubMed ID: 26194683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment results of image-guided high-dose-rate interstitial brachytherapy for pelvic recurrence of uterine cancer.
    Yoshida K; Yamazaki H; Kotsuma T; Takenaka T; Masui K; Yoshioka Y; Uesugi Y; Shimbo T; Yoshikawa N; Yoshioka H; Narumi Y; Tatsumi K; Tanaka E
    Brachytherapy; 2015; 14(4):440-8. PubMed ID: 25858904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of interstitial brachytherapy in pelvic recurrence of cervical carcinoma: Clinical response, survival, and toxicity.
    da Silva VTM; Fortuna Diniz AP; Martins J; Cursino K; Esteves SCB; Teixeira JC
    Brachytherapy; 2019; 18(2):146-153. PubMed ID: 30591409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
    Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
    Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of low- and high-dose-rate interstitial brachytherapy for T3 mobile tongue cancer.
    Kakimoto N; Inoue T; Inoue T; Murakami S; Furukawa S; Yoshida K; Yoshioka Y; Yamazaki H; Tanaka E; Shimizutani K
    Radiother Oncol; 2003 Aug; 68(2):123-8. PubMed ID: 12972306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High dose rate cobalt-60 afterloading intracavitary therapy for cervical carcinoma in Srinagarind hospital - analysis of survival.
    Pesee M; Krusun S; Padoongcharoen P
    Asian Pac J Cancer Prev; 2010; 11(6):1469-71. PubMed ID: 21338182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salvage image-guided freehand interstitial brachytherapy for pelvic sidewall recurrence after hysterectomy for uterine malignancies.
    Miyata Y; Murakami N; Okuma K; Shimizu Y; Takahashi A; Kashihara T; Kaneda T; Takahashi K; Inaba K; Sakuramachi M; Kojima K; Aoshika T; Morishima K; Nakayama Y; Itami J; Kato T; Ogo E; Igaki H
    Brachytherapy; 2022; 21(5):647-657. PubMed ID: 35750619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inversely and adaptively planned interstitial brachytherapy: A single implant approach.
    Hanania AN; Myers P; Yoder AK; Bulut A; Henry Yu Z; Eraj S; Bowers J; Bonnen MD; Echeverria A; Hall TR; Anderson ML; Ludwig M
    Gynecol Oncol; 2019 Feb; 152(2):353-360. PubMed ID: 30449720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and dosimetry analysis of image-guided radioactive ¹²⁵I seed implantation as salvage treatment for pelvic recurrent cervical cancer after external beam radiotherapy.
    Qu A; Jiang P; Sun H; Jiang W; Jiang Y; Tian S; Wang J
    J Gynecol Oncol; 2019 Jan; 30(1):e9. PubMed ID: 30479093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computed tomography planned interstitial brachytherapy for recurrent gynecologic cancer.
    Amsbaugh MJ; Bhatt N; Hunter T; Gaskins J; Parker L; Metzinger D; Amsbaugh A; Sowards K; El-Ghamry M
    Brachytherapy; 2015; 14(5):600-5. PubMed ID: 26087868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salvage High-dose-rate Interstitial Brachytherapy for Pelvic Recurrent Cervical Carcinoma After Hysterectomy.
    Murakami N; Kato T; Miyamoto Y; Nakamura S; Wakita A; Okamoto H; Tsuchida K; Kashihara T; Kobayashi K; Harada K; Kitaguchi M; Sekii S; Takahashi K; Umezawa R; Inaba K; Ito Y; Igaki H; Itami J
    Anticancer Res; 2016 May; 36(5):2413-21. PubMed ID: 27127151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose-rate interstitial brachytherapy for previously untreated cervical carcinoma.
    Isohashi F; Yoshioka Y; Koizumi M; Konishi K; Sumida I; Takahashi Y; Ogata T; Morishige KI; Enomoto T; Kawaguchi Y; Kotsuma T; Adachi K; Fukuda S; Akino Y; Inoue T
    Brachytherapy; 2009; 8(2):234-239. PubMed ID: 19213610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.